English for Bioinformatics Developers

Bioinformatics software development requires fluency in both computational vocabulary and the underlying biology, and precise English matters especially when writing methods sections, discussing pipeline results with wet-lab scientists, or debugging why a variant calling pipeline produced an unexpected result. This guide covers the essential vocabulary for that cross-disciplinary collaboration.

Key Vocabulary

Pipeline (bioinformatics pipeline) A defined, often automated sequence of computational steps that transforms raw sequencing data into interpretable results, typically involving quality control, alignment, and downstream analysis stages. Example: “Our variant calling pipeline takes raw FASTQ files through quality trimming, alignment, and variant calling before producing an annotated VCF file.”

Read (sequencing read) A single string of nucleotide bases produced by a sequencing machine, representing a short fragment of the original DNA or RNA sample. Example: “Read quality drops noticeably toward the 3’ end of these reads, which is typical for this sequencing platform and why we trim before alignment.”

Alignment (read alignment) The process of determining where each sequencing read most likely originated from within a reference genome, producing a mapping used for all downstream analysis. Example: “Alignment rate dropped to 85% on this sample, which is lower than our usual 98% — that’s worth investigating before we trust the downstream variant calls.”

Reference genome A representative, standardized genome sequence for a species, used as the coordinate system against which sequencing reads are aligned and variants are described. Example: “We need to confirm which reference genome build this dataset was aligned against, since coordinates aren’t comparable across different genome builds.”

Variant calling The process of identifying positions in the genome where a sample differs from the reference genome, such as single nucleotide changes, insertions, or deletions. Example: “The variant caller flagged this position as a heterozygous single nucleotide variant, but the read depth here is low enough that we should treat it as low-confidence.”

Coverage / depth The number of sequencing reads that overlap a given position in the genome, which directly affects confidence in any variant call made at that position. Example: “Coverage drops below 10x in this region, which is below our threshold for confident variant calling, so we flag these positions as low-confidence rather than discarding them outright.”

Reproducibility (in bioinformatics context) The ability to rerun a pipeline and obtain identical results, which is often complicated by tool version differences, reference database updates, and non-deterministic algorithm behavior. Example: “We pin exact tool versions and container images in the pipeline definition specifically to preserve reproducibility across different compute environments.”

Annotation (variant annotation) The process of adding biological context to a raw variant call — such as which gene it falls within, its predicted functional effect, and known clinical significance. Example: “This variant is annotated as falling within a coding exon and is predicted to cause a missense mutation, but its clinical significance is currently listed as uncertain.”

Common Phrases

In code reviews:

• “This pipeline step doesn’t pin the reference genome build explicitly — if someone runs it against a different build by accident, the resulting coordinates would be silently wrong.”
• “We’re not filtering by coverage before reporting these variants — low-depth calls should at least be flagged, even if we choose to still report them.”
• “This alignment step isn’t deterministic across reruns with multithreading enabled — we should either fix the seed or document that exact base-level reproducibility isn’t guaranteed here.”

In standups:

• “Yesterday I updated the pipeline to flag low-coverage variant calls instead of silently including them at full confidence; today I’m validating that change against our known truth set.”
• “I’m blocked on an alignment rate drop on the new batch of samples — I suspect a library prep issue upstream of our pipeline, not a bug in our code.”
• “I finished pinning all tool versions in the pipeline’s container definitions, which should resolve the reproducibility issue we saw between the two compute clusters.”

In meetings with wet-lab scientists or biologists:

• “The pipeline flagged this variant as low-confidence due to low coverage in that region — would it be feasible to resequence this sample at higher depth if this variant matters for your analysis?”
• “Can you confirm which reference genome build your downstream analysis expects, so we make sure our pipeline’s output coordinates are compatible?”
• “We’re seeing an unusually low alignment rate on this batch — is there anything different about how these particular samples were prepared?”

Phrases to Avoid

Saying “the pipeline is broken” for unexpected biological results. Say instead: “the alignment rate is lower than expected” or “the variant calls don’t match our positive control” — precise, specific language helps distinguish a genuine software bug from an unusual but biologically real result, which requires very different next steps.

Saying “we found a mutation” loosely. In bioinformatics and clinical genomics, “variant” and “mutation” aren’t always interchangeable — “mutation” can imply a specific causal or pathogenic role that hasn’t necessarily been established. Say instead “we identified a variant” and reserve “mutation” for cases with established functional or clinical significance.

Saying “it’s reproducible” without specifying the scope. Reproducibility can mean bit-for-bit identical output, or it can mean statistically consistent results within expected tolerance. Say instead: “the pipeline produces identical output given the same input and pinned tool versions” or “results are consistent within expected variant-calling tolerance, though not necessarily bit-identical.”

Quick Reference

Key Takeaways

• Distinguish a genuine pipeline bug from an unusual but biologically real result — use specific language (alignment rate, coverage, positive control mismatch) rather than saying the pipeline is “broken.”
• Be precise about “variant” versus “mutation” — the latter often implies established functional or clinical significance that hasn’t necessarily been demonstrated.
• Always specify which reference genome build is in use, since coordinates are meaningless without that context, and this is a common source of silent errors.
• Define reproducibility scope explicitly — bit-identical output versus statistically consistent results are very different claims.
• When collaborating with wet-lab scientists, connect pipeline findings (like low coverage) to actionable next steps they can take (like resequencing), not just the technical diagnosis alone.